{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:11:10Z","timestamp":1792606270280,"version":"4.5.0"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bone.2022.116540","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T20:11:33Z","timestamp":1661631093000},"page":"116540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"special_numbering":"C","title":["Cytokine-mediated immunomodulation of osteoclastogenesis"],"prefix":"10.1016","volume":"164","author":[{"given":"Pengcheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2022.116540_bb0005","series-title":"IOF Compendium of Osteoporosis","year":"2019"},{"issue":"10","key":"10.1016\/j.bone.2022.116540_bb0010","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","article-title":"Osteoimmunology: evolving concepts in bone-immune interactions in health and disease","volume":"19","author":"Tsukasaki","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"6812","key":"10.1016\/j.bone.2022.116540_bb0015","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","article-title":"T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.191.2.275","article-title":"Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction","volume":"191","author":"Kobayashi","year":"2000","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0025","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.4049\/jimmunol.170.5.2655","article-title":"IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand\/osteoprotegerin balance","volume":"170","author":"Lubberts","year":"2003","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.bone.2022.116540_bb0030","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/art.23138","article-title":"Treg cells suppress osteoclast formation: a new link between the immune system and bone","volume":"56","author":"Zaiss","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"235","key":"10.1016\/j.bone.2022.116540_bb0035","doi-asserted-by":"crossref","first-page":"235ra60","DOI":"10.1126\/scitranslmed.3007764","article-title":"T cell costimulation molecules CD80\/86 inhibit osteoclast differentiation by inducing the IDO\/tryptophan pathway","volume":"6","author":"Bozec","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.bone.2022.116540_bb0040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.bone.2022.116540_bb0045","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1172\/JCI141054","article-title":"Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals","volume":"130","author":"Gong","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.bone.2022.116540_bb0050","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00011-021-01484-9","article-title":"The pathophysiology of immunoporosis: innovative therapeutic targets","volume":"70","author":"Ferbebouh","year":"2021","journal-title":"Inflamm. Res."},{"issue":"9","key":"10.1016\/j.bone.2022.116540_bb0055","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"22","key":"10.1016\/j.bone.2022.116540_bb0060","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMp1202619","article-title":"Bisphosphonates for osteoporosis\u2014where do we go from here?","volume":"366","author":"Whitaker","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bone.2022.116540_bb0065","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrendo.2011.108","article-title":"Parathyroid hormone analogues in the treatment of osteoporosis","volume":"7","author":"Kraenzlin","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"19","key":"10.1016\/j.bone.2022.116540_bb0070","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.bone.2022.116540_bb0075","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0080","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"10102","key":"10.1016\/j.bone.2022.116540_bb0085","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0140-6736(17)31613-6","article-title":"Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial","volume":"390","author":"Langdahl","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bone.2022.116540_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009858","article-title":"Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus","volume":"17","author":"Zhou","year":"2021","journal-title":"PLoS Pathog."},{"issue":"44","key":"10.1016\/j.bone.2022.116540_bb0095","doi-asserted-by":"crossref","first-page":"76558","DOI":"10.18632\/oncotarget.20576","article-title":"The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"issue":"6937","key":"10.1016\/j.bone.2022.116540_bb0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1084\/jem.20050978","article-title":"Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis","volume":"202","author":"Kim","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0110","article-title":"Bone resorption is regulated by cell-autonomous negative feedback loop of Stat5\u2013Dusp axis in the osteoclast","volume":"211","author":"Jun Hirose","year":"2014","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.bone.2022.116540_bb0115","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20091957","article-title":"The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis","volume":"207","author":"Miyauchi","year":"2010","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.bone.2022.116540_bb0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nrrheum.2017.213","article-title":"Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity","volume":"14","author":"Walsh","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6237","key":"10.1016\/j.bone.2022.116540_bb0125","doi-asserted-by":"crossref","first-page":"aaa6566","DOI":"10.1126\/science.aaa6566","article-title":"Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology","volume":"348","author":"Eberl","year":"2015","journal-title":"Science"},{"issue":"6882","key":"10.1016\/j.bone.2022.116540_bb0130","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/416744a","article-title":"RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta","volume":"416","author":"Takayanagi","year":"2002","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bone.2022.116540_bb0135","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI10530","article-title":"IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB","volume":"107","author":"Abu-Amer","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0140","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1359\/jbmr.080203","article-title":"Interleukin-4 and interleukin-13 stimulate the osteoclast inhibitor osteoprotegerin by human endothelial cells through the STAT6 pathway","volume":"23","author":"Stein","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2022.116540_bb0145","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41591-019-0374-x","article-title":"Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy","volume":"25","author":"Wang","year":"2019","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.bone.2022.116540_bb0150","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1002\/jbmr.1989","article-title":"Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase\/Akt and Erk pathways in association with signaling Adaptor DAP12","volume":"28","author":"Kameda","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41413-021-00161-1","article-title":"An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP(+) mononuclear cells and PDGF-BB secretion","volume":"9","author":"Zhen","year":"2021","journal-title":"Bone Res."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00774-020-01175-1","article-title":"Discovery of the RANKL\/RANK\/OPG system","volume":"39","author":"Yasuda","year":"2021","journal-title":"J. Bone Miner. Metab."},{"issue":"3","key":"10.1016\/j.bone.2022.116540_bb0165","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1083\/jcb.145.3.527","article-title":"The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts","volume":"145","author":"Burgess","year":"1999","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bone.2022.116540_bb0175","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"issue":"26","key":"10.1016\/j.bone.2022.116540_bb0180","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1056\/NEJMcp1800214","article-title":"Glucocorticoid-induced osteoporosis","volume":"379","author":"Buckley","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bone.2022.116540_bb0185","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.stemcr.2022.06.001","article-title":"The role of CDK8 in mesenchymal stem cells in controlling osteoclastogenesis and bone homeostasis","volume":"17","author":"Yamada","year":"2022","journal-title":"Stem Cell Rep."},{"issue":"9","key":"10.1016\/j.bone.2022.116540_bb0190","doi-asserted-by":"crossref","first-page":"16503","DOI":"10.1002\/jcp.28321","article-title":"Cyclin-dependent kinase 8\/19 inhibition suppresses osteoclastogenesis by downregulating RANK and promotes osteoblast mineralization and cancellous bone healing","volume":"234","author":"Amirhosseini","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.bone.2022.116540_bb0195","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0200","first-page":"866","article-title":"Dynamic visualization of RANKL and Th17-mediated osteoclast function","volume":"123","author":"Kikuta","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bone.2022.116540_bb0205","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.immuni.2018.04.012","article-title":"The tumor necrosis factor superfamily member RANKL suppresses effector cytokine production in Group 3 innate lymphoid cells","volume":"48","author":"Bando","year":"2018","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.bone.2022.116540_bb0210","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.cdd.4401285","article-title":"M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR\/S6 kinase","volume":"10","author":"Glantschnig","year":"2003","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0215","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/0006-291X(91)92015-C","article-title":"Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro","volume":"177","author":"Hattersley","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0220","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood.V99.1.111","article-title":"Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects","volume":"99","author":"Dai","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bone.2022.116540_bb0225","first-page":"894","article-title":"High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints","volume":"27","author":"Takei","year":"2000","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.bone.2022.116540_bb0230","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1136\/ard.2006.054874","article-title":"Increased expression of macrophage colony-stimulating factor in ankylosing spondylitis and rheumatoid arthritis","volume":"65","author":"Yang","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0235","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/art.24505","article-title":"The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases","volume":"60","author":"Hamilton","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.bone.2022.116540_bb0240","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1172\/JCI26132","article-title":"M-CSF mediates TNF-induced inflammatory osteolysis","volume":"115","author":"Kitaura","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.bone.2022.116540_bb0245","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.4049\/jimmunol.1800665","article-title":"CSF-1 in inflammatory and arthritic pain development","volume":"201","author":"Saleh","year":"2018","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0250","doi-asserted-by":"crossref","DOI":"10.4110\/in.2018.18.e8","article-title":"Regulation of osteoclast differentiation by cytokine networks","volume":"18","author":"Amarasekara","year":"2018","journal-title":"Immune Netw."},{"issue":"3","key":"10.1016\/j.bone.2022.116540_bb0255","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4049\/jimmunol.0803007","article-title":"The mechanism of osteoclast differentiation induced by IL-1","volume":"183","author":"Kim","year":"2009","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bone.2022.116540_bb0260","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/intimm\/dxq431","article-title":"IL-1 plays an important role in the bone metabolism under physiological conditions","volume":"22","author":"Lee","year":"2010","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0265","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","article-title":"IL-1 mediates TNF-induced osteoclastogenesis","volume":"115","author":"Wei","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bone.2022.116540_bb0270","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00774-009-0055-9","article-title":"The effect of risedronate treatment on serum cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study","volume":"27","author":"Dundar","year":"2009","journal-title":"J. Bone Miner. Metab."},{"issue":"6","key":"10.1016\/j.bone.2022.116540_bb0275","doi-asserted-by":"crossref","first-page":"R1244","DOI":"10.1186\/ar1815","article-title":"Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis","volume":"7","author":"Guiducci","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"18","key":"10.1016\/j.bone.2022.116540_bb0280","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141008","article-title":"IL-1beta-driven osteoclastogenic Tregs accelerate bone erosion in arthritis","volume":"131","author":"Levescot","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.bone.2022.116540_bb0285","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0290","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/art.37762","article-title":"Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro","volume":"65","author":"Balani","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0295","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.bone.2011.08.003","article-title":"TNFalpha inhibits the development of osteoclasts through osteoblast-derived GM-CSF","volume":"49","author":"Atanga","year":"2011","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0300","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar2936","article-title":"Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors","volume":"12","author":"Adamopoulos","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0305","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-018-1582-3","article-title":"IL-17A induces osteoblast differentiation by activating JAK2\/STAT3 in ankylosing spondylitis","volume":"20","author":"Jo","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2022.116540_bb0310","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fimmu.2014.00425","article-title":"Effects of interleukin-17A on osteogenic differentiation of isolated human mesenchymal stem cells","volume":"5","author":"Osta","year":"2014","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.bone.2022.116540_bb0315","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/cdd.2009.74","article-title":"IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling","volume":"16","author":"Huang","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bone.2022.116540_bb0320","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2016.00057","article-title":"The role of IL-17 and TH17 cells in the bone catabolic activity of PTH","volume":"7","author":"Pacifici","year":"2016","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0325","doi-asserted-by":"crossref","first-page":"16155","DOI":"10.1038\/s41598-021-95640-0","article-title":"Increased frequency of Th17 cells and IL-17 levels are associated with low bone mineral density in postmenopausal women","volume":"11","author":"Bhadricha","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0330","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00198-013-2548-6","article-title":"IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis","volume":"25","author":"Molnar","year":"2014","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0335","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.bone.2022.116540_bb0340","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11914-017-0358-z","article-title":"TNF and Bone remodeling","volume":"15","author":"Zhao","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0345","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1074\/jbc.M008198200","article-title":"Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways","volume":"276","author":"Zhang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2022.116540_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.583561","article-title":"Intrinsic restriction of TNF-mediated inflammatory osteoclastogenesis and bone resorption","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0355","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar1857","article-title":"Osteoclasts; culprits in inflammatory osteolysis","volume":"8","author":"Teitelbaum","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2022.116540_bb0360","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopha.2018.03.080","article-title":"TNF-alpha contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation","volume":"102","author":"Zha","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bone.2022.116540_bb0365","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fimmu.2014.00048","article-title":"Classical and paradoxical effects of TNF-alpha on bone homeostasis","volume":"5","author":"Osta","year":"2014","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.bone.2022.116540_bb0370","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","article-title":"Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7","key":"10.1016\/j.bone.2022.116540_bb0375","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1359\/jbmr.090533","article-title":"Osteoclasts and arthritis","volume":"24","author":"Schett","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0380","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.bone.2022.116540_bb0385","doi-asserted-by":"crossref","first-page":"iii42","DOI":"10.1136\/ard.2007.078972","article-title":"Joint remodelling in inflammatory disease","volume":"66","author":"Schett","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0390","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jre.12339","article-title":"The effects of tumour necrosis factor-alpha on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes","volume":"51","author":"Algate","year":"2016","journal-title":"J. Periodontal Res."},{"issue":"10","key":"10.1016\/j.bone.2022.116540_bb0395","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/stem.703","article-title":"Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1","volume":"29","author":"Zhao","year":"2011","journal-title":"Stem Cells"},{"issue":"7","key":"10.1016\/j.bone.2022.116540_bb0400","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1074\/jbc.M509430200","article-title":"Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts","volume":"281","author":"Kaneki","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bone.2022.116540_bb0405","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1172\/JCI68901","article-title":"NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-kappaB","volume":"124","author":"Zhang","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2022.116540_bb0410","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3389\/fimmu.2017.01376","article-title":"Interleukin-7 induces osteoclast formation via STAT5, independent of receptor activator of NF-kappaB ligand","volume":"8","author":"Kim","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0415","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1073\/pnas.0136772100","article-title":"IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells","volume":"100","author":"Toraldo","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0420","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41591-020-0873-9","article-title":"IL-8 and cancer prognosis on immunotherapy","volume":"26","author":"Bakouny","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0425","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","article-title":"Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease","volume":"33","author":"Bendre","year":"2003","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bone.2022.116540_bb0430","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1242\/bio.20148128","article-title":"Autocrine signaling is a key regulatory element during osteoclastogenesis","volume":"3","author":"Kopesky","year":"2014","journal-title":"Biol. Open"},{"issue":"8","key":"10.1016\/j.bone.2022.116540_bb0435","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.ajpath.2016.04.003","article-title":"Effects of IL-8 up-regulation on cell survival and osteoclastogenesis in multiple myeloma","volume":"186","author":"Herrero","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.bone.2022.116540_bb0440","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/annrheumdis-2015-208093corr1","article-title":"Correction: identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss","volume":"78","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0445","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrrheum.2015.177","article-title":"Rheumatoid arthritis: osteoclasts and ACPAs\u2014the joint link","volume":"12","author":"Duarte","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bone.2022.116540_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2022.01.004","article-title":"Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity","author":"Zhou","year":"2022","journal-title":"Cytokine & Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.bone.2022.116540_bb0455","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.micinf.2011.10.006","article-title":"The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use","volume":"14","author":"Perera","year":"2012","journal-title":"Microbes Infect."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0460","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.4049\/jimmunol.162.5.2754","article-title":"A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2","volume":"162","author":"Ogata","year":"1999","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bone.2022.116540_bb0465","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/jcb.25726","article-title":"IL-15 and RANKL play a synergistically important role in osteoclastogenesis","volume":"118","author":"Okabe","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0470","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00960-17","article-title":"Antibiotics with interleukin-15 inhibition reduce joint inflammation and bone erosions but not cartilage destruction in Staphylococcus aureus-induced arthritis","volume":"86","author":"Bergmann","year":"2018","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.bone.2022.116540_bb0475","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.4049\/jimmunol.173.9.5818","article-title":"Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15\/Fc protein prevents disease development and progression in murine collagen-induced arthritis","volume":"173","author":"Ferrari-Lacraz","year":"2004","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bone.2022.116540_bb0480","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10753-013-9782-0","article-title":"Effect of IL-15 and natural killer cells on osteoclasts and osteoblasts in a mouse coculture","volume":"37","author":"Takeda","year":"2014","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.bone.2022.116540_bb0485","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/imm.12449","article-title":"Interleukin-15-activated natural killer cells kill autologous osteoclasts via LFA-1, DNAM-1 and TRAIL, and inhibit osteoclast-mediated bone erosion in vitro","volume":"145","author":"Feng","year":"2015","journal-title":"Immunology"},{"issue":"7542","key":"10.1016\/j.bone.2022.116540_bb0490","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature14115","article-title":"Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity","volume":"519","author":"Brestoff","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0495","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1038\/s41467-020-18601-7","article-title":"DR3 stimulation of adipose resident ILC2s ameliorates type 2 diabetes mellitus","volume":"11","author":"Shafiei-Jahani","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.bone.2022.116540_bb0500","first-page":"938","article-title":"Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells, nature medicine","volume":"23","author":"Rauber","year":"2017"},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0505","first-page":"1","article-title":"Th2 and eosinophil responses suppress inflammatory arthritis","volume":"7","author":"Chen","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0510","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.celrep.2018.06.005","article-title":"Group 2 innate lymphoid cells attenuate inflammatory arthritis and protect from bone destruction in mice","volume":"24","author":"Omata","year":"2018","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.bone.2022.116540_bb0515","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0520","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nri.2017.118","article-title":"TH2 cell development and function","volume":"18","author":"Walker","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0525","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Archives Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0530","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4049\/jimmunol.175.2.917","article-title":"IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-kappa B and Ca2+ signaling","volume":"175","author":"Mangashetti","year":"2005","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0535","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1073\/pnas.041493198","article-title":"IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1","volume":"98","author":"Bendixen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bone.2022.116540_bb0540","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/09513590.2014.975683","article-title":"Changes of serum cytokines-related Th1\/Th2\/Th17 concentration in patients with postmenopausal osteoporosis","volume":"31","author":"Zhang","year":"2015","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.bone.2022.116540_bb0545","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2567.2006.02538.x","article-title":"Interleukin-4 inhibition of osteoclast differentiation is stronger than that of interleukin-13 and they are equivalent for induction of osteoprotegerin production from osteoblasts","volume":"120","author":"Yamada","year":"2007","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.bone.2022.116540_bb0550","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI11232","article-title":"Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice","volume":"107","author":"Macias","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0555","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1021\/acs.est.0c03758","article-title":"Chlorinated flame-retardant Dechlorane 602 potentiates type 2 innate lymphoid cells and exacerbates airway inflammation","volume":"55","author":"Zhou","year":"2020","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.bone.2022.116540_bb0560","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.726035","article-title":"Huangbai liniment ameliorates skin inflammation in atopic dermatitis","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bone.2022.116540_bb0565","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3389\/fimmu.2019.02918","article-title":"T follicular helper cell subsets and the associated cytokine IL-21 in the pathogenesis and therapy of asthma","volume":"10","author":"Gong","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bone.2022.116540_bb0570","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.immuni.2006.09.013","article-title":"Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse","volume":"25","author":"Kamanaka","year":"2006","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bone.2022.116540_bb0575","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2121-8-4","article-title":"Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus","volume":"8","author":"Evans","year":"2007","journal-title":"BMC Cell Biol."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0585","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1359\/jbmr.2000.15.5.911","article-title":"The inhibitory effect of interleukin-10 on mouse osteoclast formation involves novel tyrosine-phosphorylated proteins","volume":"15","author":"Hong","year":"2000","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0590","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0722.2006.00283.x","article-title":"Effect of interleukin-10 on gene expression of osteoclastogenic regulatory molecules in the rat dental follicle","volume":"114","author":"Liu","year":"2006","journal-title":"Eur. J. Oral Sci."},{"issue":"3","key":"10.1016\/j.bone.2022.116540_bb0595","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.gastro.2004.06.013","article-title":"Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones","volume":"127","author":"Dresner-Pollak","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0600","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0722.2009.00706.x","article-title":"Down-regulation of expression of osteoblast and osteocyte markers in periodontal tissues associated with the spontaneous alveolar bone loss of interleukin-10 knockout mice","volume":"118","author":"Claudino","year":"2010","journal-title":"Eur. J. Oral Sci."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0605","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00296-002-0223-x","article-title":"Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy","volume":"22","author":"G\u00fcr","year":"2002","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0610","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejogrb.2005.02.003","article-title":"Tumor necrosis factor \u03b1, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis","volume":"122","author":"Chen","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"6","key":"10.1016\/j.bone.2022.116540_bb0615","doi-asserted-by":"crossref","first-page":"691","DOI":"10.5483\/BMBRep.2004.37.6.691","article-title":"Association of interleukin 10 haplotype with low bone mineral density in Korean postmenopausal women","volume":"37","author":"Park","year":"2004","journal-title":"BMB Rep."},{"issue":"10","key":"10.1016\/j.bone.2022.116540_bb0620","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","article-title":"Biology and regulation of IL-2: from molecular mechanisms to human therapy","volume":"18","author":"Spolski","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bone.2022.116540_bb0625","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0630","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jcb.20316","article-title":"Stat1-mediated cytoplasmic attenuation in osteoimmunology","volume":"94","author":"Takayanagi","year":"2005","journal-title":"J. Cell. Biochem."},{"issue":"33","key":"10.1016\/j.bone.2022.116540_bb0635","doi-asserted-by":"crossref","first-page":"11917","DOI":"10.1073\/pnas.0502188102","article-title":"Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression","volume":"102","author":"Coelho","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0640","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1038\/s41467-018-06446-0","article-title":"Bone protection by inhibition of microRNA-182","volume":"9","author":"Inoue","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bone.2022.116540_bb0645","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.4049\/jimmunol.1601716","article-title":"Def6 restrains osteoclastogenesis and inflammatory bone resorption","volume":"198","author":"Binder","year":"2017","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.bone.2022.116540_bb0650","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.bone.2022.116540_bb0655","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S8756-3282(03)00213-8","article-title":"Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population","volume":"33","author":"Nagata","year":"2003","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bone.2022.116540_bb0660","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.4049\/jimmunol.169.9.4732","article-title":"Effect of IL-12 on TNF-alpha-mediated osteoclast formation in bone marrow cells: apoptosis mediated by Fas\/Fas ligand interaction","volume":"169","author":"Kitaura","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2022.116540_bb0665","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/214878","article-title":"IL-12 inhibits lipopolysaccharide stimulated osteoclastogenesis in mice","volume":"2015","author":"Yoshimatsu","year":"2015","journal-title":"J Immunol Res"},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0670","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bone.2009.07.079","article-title":"IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo","volume":"45","author":"Yoshimatsu","year":"2009","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0675","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.27200","article-title":"Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling","volume":"62","author":"Kalliolias","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.bone.2022.116540_bb0680","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.4049\/jimmunol.0802091","article-title":"IL-27 abrogates receptor activator of NF-kappa B ligand-mediated osteoclastogenesis of human granulocyte-macrophage colony-forming unit cells through STAT1-dependent inhibition of c-Fos","volume":"183","author":"Furukawa","year":"2009","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.bone.2022.116540_bb0685","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1074\/jbc.M116.764779","article-title":"Interleukin 27 (IL-27) alleviates bone loss in estrogen-deficient conditions by induction of early growth response-2 gene","volume":"292","author":"Shukla","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bone.2022.116540_bb0690","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.4049\/jimmunol.0900072","article-title":"Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-\u03b3 in human osteoclast precursors","volume":"183","author":"Ji","year":"2009","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bone.2022.116540_bb0695","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/cdd.2015.14","article-title":"Osteoblast-induced osteoclast apoptosis by fas ligand\/FAS pathway is required for maintenance of bone mass","volume":"22","author":"Wang","year":"2015","journal-title":"Cell Death Different."},{"issue":"11","key":"10.1016\/j.bone.2022.116540_bb0700","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1359\/jbmr.1997.12.11.1797","article-title":"Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity","volume":"12","author":"Van\u2019t Hof","year":"1997","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0705","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5483\/BMBRep.2012.45.5.281","article-title":"Effect of interferon-\u03b3 on the fusion of mononuclear osteoclasts into bone-resorbing osteoclasts","volume":"45","author":"Kim","year":"2012","journal-title":"BMB Rep."},{"issue":"7","key":"10.1016\/j.bone.2022.116540_bb0710","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/jbmr.350","article-title":"Interferon-\u03b3 plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice","volume":"26","author":"Duque","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2022.116540_bb0715","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1600-0765.1989.tb01788.x","article-title":"Interleukin-2 stimulates osteoclastic activity; increased acid production and radioactive calcium release","volume":"24","author":"Ries","year":"1989","journal-title":"J. Periodontal Res."},{"issue":"6","key":"10.1016\/j.bone.2022.116540_bb0720","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1074-7613(03)00326-1","article-title":"Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin","volume":"19","author":"Ashcroft","year":"2003","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.bone.2022.116540_bb0725","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.4049\/jimmunol.169.6.3353","article-title":"IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-\u03baB ligand, osteoprotegerin, and receptor activator of NF-\u03baB in mouse calvariae","volume":"169","author":"Palmqvist","year":"2002","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(02)00915-8","article-title":"Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism","volume":"32","author":"Kudo","year":"2003","journal-title":"Bone"},{"issue":"17","key":"10.1016\/j.bone.2022.116540_bb0735","doi-asserted-by":"crossref","first-page":"11535","DOI":"10.1074\/jbc.M607999200","article-title":"Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-\u03baB signaling pathways","volume":"283","author":"Yoshitake","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bone.2022.116540_bb0745","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188454","article-title":"Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bone.2022.116540_bb0750","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/eji.200838192","article-title":"IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kappaB (RANK) expression in myeloid precursor cells","volume":"38","author":"Chen","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0755","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4049\/jimmunol.1401013","article-title":"Crosstalk among IL-23 and DNAX activating protein of 12\u00a0kDa-dependent pathways promotes osteoclastogenesis","volume":"194","author":"Shin","year":"2015","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0760","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1172\/JCI28508","article-title":"The IL-23\/IL-17 axis in inflammation","volume":"116","author":"Iwakura","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0765","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/ar2297","article-title":"IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats","volume":"9","author":"Yago","year":"2007","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.bone.2022.116540_bb0770","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.4049\/jimmunol.181.8.5720","article-title":"IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in mice","volume":"181","author":"Quinn","year":"2008","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bone.2022.116540_bb0775","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00774-007-0766-8","article-title":"Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation","volume":"25","author":"Kamiya","year":"2007","journal-title":"J. Bone Miner. Metab."},{"issue":"6","key":"10.1016\/j.bone.2022.116540_bb0780","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/annrheumdis-2013-204741","volume":"73","author":"Kavanaugh","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"1\u20132","key":"10.1016\/j.bone.2022.116540_bb0785","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cellimm.2005.02.004","article-title":"Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGF\u03b21-deficient mice","volume":"232","author":"Bommireddy","year":"2004","journal-title":"Cell. Immunol."},{"issue":"2","key":"10.1016\/j.bone.2022.116540_bb0790","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1172\/JCI70050","article-title":"Bone marrow mesenchymal stem cells and TGF-\u03b2 signaling in bone remodeling","volume":"124","author":"Crane","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0795","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-3701-3-4","article-title":"TGF-beta1 on osteoimmunology and the bone component cells","volume":"3","author":"Kasagi","year":"2013","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bone.2022.116540_bb0800","doi-asserted-by":"crossref","first-page":"16009","DOI":"10.1038\/boneres.2016.9","article-title":"TGF-beta and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease","volume":"4","author":"Wu","year":"2016","journal-title":"Bone Res."},{"issue":"10","key":"10.1016\/j.bone.2022.116540_bb0805","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1359\/jbmr.2001.16.10.1787","article-title":"Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions","volume":"16","author":"Quinn","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2022.116540_bb0810","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/jbmr.357","article-title":"Regulation of RANKL-induced osteoclastogenesis by TGF-beta through molecular interaction between Smad3 and Traf6","volume":"26","author":"Yasui","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116540_bb0815","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.imlet.2018.12.003","article-title":"A dual role of TGF-\u03b2 in human osteoclast differentiation mediated by Smad1 versus Smad3 signaling","volume":"206","author":"Lee","year":"2019","journal-title":"Immunol. Lett."},{"issue":"35","key":"10.1016\/j.bone.2022.116540_bb0820","doi-asserted-by":"crossref","first-page":"23397","DOI":"10.1074\/jbc.M109.019372","article-title":"Transforming growth factor-beta1 (TGF-beta1) induces human osteoclast apoptosis by up-regulating Bim","volume":"284","author":"Houde","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bone.2022.116540_bb0825","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.4049\/jimmunol.165.8.4254","article-title":"Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor","volume":"165","author":"Kaneda","year":"2000","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0830","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jcp.20036","article-title":"Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation","volume":"200","author":"Karst","year":"2004","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bone.2022.116540_bb0835","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1038\/s41467-022-31475-1","article-title":"TGFbeta reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis","volume":"13","author":"Xia","year":"2022","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bone.2022.116540_bb0840","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nm.3143","article-title":"Inhibition of TGF-\u03b2 signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis","volume":"19","author":"Zhen","year":"2013","journal-title":"Nat. Med."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222002174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222002174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:44:50Z","timestamp":1762659890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328222002174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":167,"alternative-id":["S8756328222002174"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2022.116540","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine-mediated immunomodulation of osteoclastogenesis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2022.116540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116540"}}